推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Journal of Bone Oncology

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 最新评论:暂无评论!


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Journal of Bone Oncology期刊基本信息Hello,您是该期刊的第14220位访客

基本信息 登录收藏
期刊名字Journal of Bone OncologyJournal of Bone Oncology

J BONE ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.9
50人评分
我要评分

声誉
7.1

影响力
4.8

速度
7.0

期刊ISSN2212-1366
微信扫码收藏此期刊
E-ISSN2212-1374
2022-2023最新影响因子
(数据来源于搜索引擎)
3.4 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:2.638
2022-2023自引率2.90%点击查看自引率趋势图
五年影响因子3.8
h-index 15
CiteScore
CiteScoreSJRSNIPCiteScore排名
7.200.9201.293
学科分区排名百分位
大类:Medicine
小类:Oncology
Q294 / 366

期刊简介
The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.

As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.

The areas covered by the journal include:

Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
Preclinical models of metastasis
Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)
Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)
Bone imaging (clinical and animal, skeletal interventional radiology)
Bone biomarkers (clinical and translational applications)
Radiotherapy and radio-isotopes
Skeletal complications
Bone pain (mechanisms and management)
Orthopaedic cancer surgery
Primary bone tumours
Clinical guidelines
Multidisciplinary care
Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.
期刊官方网站http://www.journals.elsevier.com/journal-of-bone-oncology/
期刊投稿网址https://www.editorialmanager.com/JBO
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Journal of Bone Oncology的语言要求,还能让Journal of Bone Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Journal of Bone Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD1950; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:bone oncology、cancer、cancer treatment、radiotherapy、surgery、pharmacology
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
出版商Elsevier GmbH
涉及的研究方向ONCOLOGY-
出版国家或地区NETHERLANDS
出版语言English
出版周期
出版年份0
年文章数 53点击查看年文章数趋势图
Gold OA文章占比96.61%
研究类文章占比:
文章 ÷(文章 + 综述)
75.47%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:3区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q3125/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区1区
ONCOLOGY
肿瘤学
3区4区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
1区3区3区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区2区
ONCOLOGY
肿瘤学
1区2区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2212-1366%5BISSN%5D
平均审稿速度网友分享经验:
20 Weeks
平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Journal of Bone Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Journal of Bone Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Journal of Bone Oncology中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Journal of Bone Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599807
    BIOMATERIALS512663
    BIOMEDICINE & PHARMACOTHERAPY461811
    Journal of Materials Chemistry B458381
    Frontiers in Pharmacology448170
    Frontiers in Immunology419152
    JOURNAL OF ETHNOPHARMACOLOGY403551
    COLLOIDS AND SURFACES B-BIOINTERFACES403064
    Frontiers in Oncology382467
    Acta Biomaterialia374599
  •  

    Journal of Bone Oncology Journal of Bone Oncology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Surgical options and reconstruction strategies for primary bone tumors of distal tibia: A systematic review of complications and functional outcome.

    Author: Zhao Z1, Yan T1, Guo W1, Yang R1, Tang X1, Wang W1.
    Journal: J Bone Oncol. 2018 Dec 4;14:100209. doi: 10.1016/j.jbo.2018.100209. eCollection 2019 Feb.
        PubMed      DOI
    2.Feasibility of total en-bloc spondylectomy on L5 by a posterior-only approach: An autopsy study.

    Author: Dai T1, Pan T1, Zhang X1, Chen G1, Lu P1, Shi K1.
    Journal: J Bone Oncol. 2018 Nov 6;14:100204. doi: 10.1016/j.jbo.2018.10.003. eCollection 2019 Feb.
        PubMed      DOI
    3.The need for bone biopsies in the diagnosis of new bone lesions in patients with a known primary malignancy: A comparative review of 117 biopsy cases.

    Author: Zhang L1, Wang Y1, Gu Y1, Hou Y2, Chen Z1.
    Journal: J Bone Oncol. 2018 Dec 18;14:100213. doi: 10.1016/j.jbo.2018.100213. eCollection 2019 Feb.
        PubMed      DOI
    4.Managements of giant cell tumor within the distal radius: A retrospective study of 58 cases from a single center.

    Author: Zou C1, Lin T1, Wang B1, Zhao Z1, Li B2, Xie X1, Huang G1, Yin J1, Shen J1.
    Journal: J Bone Oncol. 2018 Dec 14;14:100211. doi: 10.1016/j.jbo.2018.100211. eCollection 2019 Feb.
        PubMed      DOI
    5.Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.

    Author: Li S1, Chen P1, Yang Q1.
    Journal: J Bone Oncol. 2019 Jan 23;15:100217. doi: 10.1016/j.jbo.2019.100217. eCollection 2019 Apr.
        PubMed      DOI
    6.Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis.

    Author: Zhu M1, Liu X1, Qu Y2, Hu S2, Zhang Y2, Li W1, Zhou X1, Yang H1, Zhou L1, Wang Q1, Hou Y1, Chen Y1, Wang Y1, Wang Y1, Lu Z1, Luo Z1, Hu X1.
    Journal: J Bone Oncol. 2019 Jan 23;15:100219. doi: 10.1016/j.jbo.2019.100219. eCollection 2019 Apr.
        PubMed      DOI
    7.A nomogram to predict prognosis in Ewing sarcoma of bone.

    Author: Zhou Q1, Wu ZY2, Lin ZQ1.
    Journal: J Bone Oncol. 2019 Feb 12;15:100223. doi: 10.1016/j.jbo.2019.100223. eCollection 2019 Apr.
        PubMed      DOI
    8.Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study.

    Author: Huang X1, Zhao J2, Bai J2, Shen H3, Zhang B1, Deng L1, Sun C1, Liu Y1, Zhang J1, Zheng J1.
    Journal: J Bone Oncol. 2019 Mar 7;16:100230. doi: 10.1016/j.jbo.2019.100230. eCollection 2019 Jun.
        PubMed      DOI
    9.Bone transport using the Ilizarov method for osteosarcoma patients with tumor resection and neoadjuvant chemotherapy.

    Author: Wang W1, Yang J2, Wang Y3, Han G1, Jia JP1, Xu M1, Bi WZ1.
    Journal: J Bone Oncol. 2019 Feb 12;16:100224. doi: 10.1016/j.jbo.2019.100224. eCollection 2019 Jun.
        PubMed      DOI
    10.Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway.

    Author: Ma H1, Su R2, Feng H3, Guo Y3, Su G3.
    Journal: J Bone Oncol. 2019 Mar 1;16:100228. doi: 10.1016/j.jbo.2019.100228. eCollection 2019 Jun.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共0条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451